Figure 2.
Mean plasma concentration of tegoprazan and its metabolite (M1) after a single oral administration of tegoprazan 50 mg in the fasted state, at 30 min before a high‐fat meal or at 30 min after a high‐fat meal. (a) Tegoprazan and (b) M1
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.